All About Positive Health

Just another Blog Engage Bloggers Club weblog

  • RSS ClinicianOnNet

    • Links for 2012-01-31 [Digg] February 1, 2012
      Bedsores can be Responsible for Considerable Morbidity and Mortality Bedsores can kill almost as many as the hospital superbug MRSA (Methicillin Resistant Staphylococcus Aureus) and cost a lot to the exchequer anywhere in the world. Even when they don’t kill, they inflict terrible pain, discomfort; and rob the sufferer of their time and money. Read more; htt […]
    • Bedsores can be Responsible for Considerable Morbidity and Mortality January 31, 2012
      Bedsores can kill almost as many as the hospital superbug MRSA (Methicillin Resistant Staphylococcus Aureus) and cost a lot to the exchequer anywhere in the world. Even when they don’t kill, they... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] […]
    • Links for 2012-01-30 [Digg] January 31, 2012
      Melatonin and Risk of Developing Diabetes Mellitus In addition to inducing sleep, it also acts on different organs of body and influence their functions too. So it regulates the “biological clock” responsible for sleep/wake pattern. It has been seen that people engaged in night shift duty are prone to develop type II diabetes (DM Type II) mellitus, obesity a […]
  • Get it Delivered to YOU.

    Enter your email address:

    Delivered by FeedBurner

  • Recent Comments

  • Meta


  • 0
    Unique
    Visitors
    Powered By Google Analytics
  • Pages

  • Recently Active Member Avatars

    Member avatar
    Member avatar
    Member avatar
    Member avatar
    Member avatar

More Evidence that PPIs Blunt Antiplatelet Activity

Posted by Dr.Prahallad Panda on April 30, 2010

This link;”http://www.medpagetoday.com/MeetingCoverage/AHA/17058″, is all about the warning of FDA in concomitant use of some proton pump inhibitors (PPI) with clopidogrel; a blood thinning agent usually prescribed after stent placements and other cases of coronary artery disease treatment. It has been seen by the researchers that pantaprazole a PPI prescribed to reduce adverse effect of aspirin, which is also co-prescribed along with clopidogrel may interfere with the action of clopidogrel, adversely affecting the task of blood thinning.
clipped from www.medpagetoday.com
The risk of rehospitalization for myocardial infarction (MI) almost doubled in patients treated with both a proton pump inhibitor (PPI) and clopidogrel (Plavix) after acute MI or coronary stent deployment, data from a retrospective cohort study showed.

PPIs are frequently used to reduce the risk of gastrointestinal bleeding in patients treated with clopidogrel. However, a growing volume of evidence has suggested that PPIs might reduce clopidogrel’s efficacy, the authors wrote.

In one recent study, patients treated with omeprazole (Prilosec) in addition to aspirin and clopidogrel had a significantly higher platelet reactivity index score after seven days of treatment than patients who didn’t get the PPI (J Am Coll Cardiol 2008; 51: 256-60).

However, a subgroup analysis of a large clinical trial showed no increased risk of adverse events in patients who received clopidogrel with or without a PPI (Circulation 2008; 118(suppl 2): Abstract 3999).

  blog it

Leave a Reply



XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>